glp 1 insulin resistance Study shows liraglutide results in increased sensitivity independent of weight loss Understanding Insulin Resistance: Envizion Medical:

The tissue was then digested for 15 min in a 37 C shaking water bath incubator using 5 ml of 100 U/ml collagenase type I (Sigma) in Basal Medium Eagle (Thermo Fisher Scientific) and supplemented with 1% BSA, 26.4 mM N a HCO 3 , and 10 mM HEPES (pH 6.9)

By combining GLP-1 receptor agonists with other agents, such as GIP or glucagon receptor agonists, researchers are achieving greater weight loss, improved glycemic control, and broader metabolic benefits

Compounded GLP-1s have not been evaluated by the FDA, but side effects are expected to be similar to other GLP-1-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)

Mechanisms Behind GLP-1 Induced Weight Loss

A: Martinez de Andino: It depends on the medication, In the clinical trials, people lost around 15 to 20% of their total body weight